SANUWAVE Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for SANUWAVE Health (SNWV).

Price Target Range — 2 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingOutperform# Analysts2Avg. Consensus PT$51Upside to Avg. PT+790.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Mar 30, 2026	Roth Capital	Kyle Bauser	PT Cut	Buy	$53→$47
Sep 3, 2025	Northland Capital Markets	Carl Byrnes	Initiate	Outperform	$55
Aug 22, 2025	Roth Capital	Kyle Bauser	PT Raise	Buy	$54→$55
Jul 29, 2025	Roth Capital	Kyle Bauser	Initiate	Buy	$49

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Roth Capital Reiterates Buy on SANUWAVE Health, Lowers Price Target to $47

Roth Capital analyst Kyle Bauser reiterates SANUWAVE Health (NASDAQ:SNWV) with a Buy and lowers the price target from $53 to $47.

Benzinga Newsdesk

Stock Market Today: Dow Jones, Nasdaq 100, S&P 500 Futures Turn Green—Trilogy Metals, AMD, Applovin In Focus (UPDATED)

Editor’s Note: The future prices of benchmark tracking ETFs and lede were updated in the story.) US futures trimmed earlier losses to trade slightly above the flatline on Tuesday, following Monday’s mixed moves. Futures of major benchmark indices were trading higher.

Rishabh Mishra

PRO
Northland Capital Markets Initiates Coverage On SANUWAVE Health with Outperform Rating, Announces Price Target of $55

Northland Capital Markets analyst Carl Byrnes initiates coverage on SANUWAVE Health (NASDAQ:SNWV) with a Outperform rating and announces Price Target of $55.

Benzinga Newsdesk

PRO
Roth Capital Maintains Buy on SANUWAVE Health, Raises Price Target to $55

Roth Capital analyst Kyle Bauser maintains SANUWAVE Health (NASDAQ:SNWV) with a Buy and raises the price target from $54 to $55.

Benzinga Newsdesk

PRO
Roth Capital Initiates Coverage On SANUWAVE Health with Buy Rating, Announces Price Target of $49

Roth Capital analyst Kyle Bauser initiates coverage on SANUWAVE Health (NASDAQ:SNWV) with a Buy rating and announces Price Target of $49.

Benzinga Newsdesk

PRO
Lake Street Initiates Coverage On SANUWAVE Health with Buy Rating, Announces Price Target of $0.34

Lake Street analyst Brooks O'Neil initiates coverage on SANUWAVE Health (OTC:SNWV) with a Buy rating and announces Price Target of $0.34.

Benzinga Newsdesk

SANUWAVE Health Inc

SANUWAVE Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Roth Capital Reiterates Buy on SANUWAVE Health, Lowers Price Target to $47

Stock Market Today: Dow Jones, Nasdaq 100, S&P 500 Futures Turn Green—Trilogy Metals, AMD, Applovin In Focus (UPDATED)

PRO
Northland Capital Markets Initiates Coverage On SANUWAVE Health with Outperform Rating, Announces Price Target of $55

PRO
Roth Capital Maintains Buy on SANUWAVE Health, Raises Price Target to $55

PRO
Roth Capital Initiates Coverage On SANUWAVE Health with Buy Rating, Announces Price Target of $49

PRO
Lake Street Initiates Coverage On SANUWAVE Health with Buy Rating, Announces Price Target of $0.34

People Also Watch

People Also Watch

SANUWAVE Health Inc

SANUWAVE Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRORoth Capital Reiterates Buy on SANUWAVE Health, Lowers Price Target to $47

Stock Market Today: Dow Jones, Nasdaq 100, S&P 500 Futures Turn Green—Trilogy Metals, AMD, Applovin In Focus (UPDATED)

PRONorthland Capital Markets Initiates Coverage On SANUWAVE Health with Outperform Rating, Announces Price Target of $55

PRORoth Capital Maintains Buy on SANUWAVE Health, Raises Price Target to $55

PRORoth Capital Initiates Coverage On SANUWAVE Health with Buy Rating, Announces Price Target of $49

PROLake Street Initiates Coverage On SANUWAVE Health with Buy Rating, Announces Price Target of $0.34

People Also Watch

People Also Watch

PRO
Roth Capital Reiterates Buy on SANUWAVE Health, Lowers Price Target to $47

PRO
Northland Capital Markets Initiates Coverage On SANUWAVE Health with Outperform Rating, Announces Price Target of $55

PRO
Roth Capital Maintains Buy on SANUWAVE Health, Raises Price Target to $55

PRO
Roth Capital Initiates Coverage On SANUWAVE Health with Buy Rating, Announces Price Target of $49

PRO
Lake Street Initiates Coverage On SANUWAVE Health with Buy Rating, Announces Price Target of $0.34